Investment Q&A

Q: Just a comment to add to your comments about NFI in a previous question.
While the 40 electric busses ordered by Montreal & Laval may not be significant as compared to the 4,000 they have sold in the last 12 months,
the more important thing is breaking into the Quebec market (probably the
2nd largest market in Canada next to Toronto/Ontario). Lets face it Quebec is notorious for paying whatever price to support Quebec companies. Should these buses perform well it could be very beneficial to NFI.

Q: Covalon has spent just over $700K on R&D for the six months recently reported according to my reading of the financials. This is a small number for a company looking to grow significantly. How can they develop new products with such a low ongoing investment? How do you see this?

Q: Own NFI and CIX. Looking to diversify with a high growth stock - PBH? I know you are bullish on it. What's caused the recent drop?

Q: From your balanced and income portfolios which would you suggest with $25000 to invest? Income primary but some growth as well.
Many thanks for all you have done and continue to do for us.
Harold

Q: Hi 5i - I have about 35% in cash coming soon and Im looking at how to deploy it. Here are my top holdings:

ENB - 5.4%
KXS - 4.7%
SIS - 4.2%
BNS - 4.2%
PBH - 3.6%
T - 3.5%
WSP - 3.4%
HR.UN - 3.2%
CGX - 2.5%
TSGI - 2.5%
GUD - 2.1%
TOG - 2%
VET - 2%
PHO - 2%
KWH.UN - 2%
CPG - 2%

Are the any positions you would top up to 5% or new positions that I should add? Thanks, Neil

Q: FYI The UK gov has posted Oct 18 as deadline for phase one decision of competition review of TSGI/Sky deal. See link below.
https://www.gov.uk/cma-cases/stars-uk-sky-betting-and-gaming-merger-inquiry

Any Thoughts on the outcome?

Q: Would you please provide your assessment of the announcement by NFI.......'Montréal and Laval award Canada's largest ever battery-electric bus contract to New Flyer' Any idea of the financial impact to NFI....Thanks

Q: Hi Team,

It would be nice to have a column in the Portfolio report indicating a recommended price range for buying any stock for new money. The "Start Price" column shows the price when 5i added the stock to the portfolio which could have been a long time ago and the current valuation of the stock may be very high in terms of price. Alternatively if the stock is in the portfolio report does it mean it is always a buy recommendation ?

Appreciate all the work done by 5i Team.

Thanks
Ninad

Q: can you make the current case for holding this company please.
Would you add to a position here - its a bit of a disaster
for anyone buying in this year.

Q: What are your expectations of BNS"s Q results on Aug 29.How would its international exposure(no USA,arguably the best place) & recent very big bing in acquistions(say,$6/8b) over a very short period impact the results? Would U buy before results.Know that U recommend it for long term.Thanks for usual great services & views

Q: What are your thoughts on on the acquisition of Spectra? Is it just sort of tidying things up or is it noteworthy in some way? Thank-you.

Q: Hi 5I team, of the above mentioned companies, which one would you add today to bring into full position ? thanks.

Q: Hi there, I've been reading the Q&A section regrading optimal portfolio size. If you had to craft the "perfect" portfolio ranging from the 15 - 20 small to mid cap holdings, what would it look like? A guidance for risk tolerance for me would include names along the lines of KXS, SIS, DOO or GSY. Thanks so much.

Q: Hi 5i,
I know that speculating on takeovers is not something you advocate but do you think Covalon may be heading for a buyout? The recently announced licensing agreement with “a large global medical company” reminds me of the deal that Pure signed with Xylem, leading to the takeout of Pure less than a year (I think) later. It looks like a ‘test drive’ of marketing COV’s product and services suite. If the larger company becomes convinced it can sell the product, preserve the margins, and scale that across a larger market, a buyout is a likely next step, isn’t it? Plus, the described global medical company is presumably not Canada-based. For a non-Canadian acquirer, the perceived Saudi-Canada relations risk would likely be a non-issue. Thanks!

Q: Hello 5i Team,
What do you think about the short report on Stars Group? The Co. seems to have countered most of the negative points raised. Also, is the short position big and/or still growing?
Thanks for your usual help.

Q: Hello 5i Team. My understanding is that there are 2 significant issues here. US tariffs, and recent miss on performance. I've just recently started managing my own rsp, I'm finding mg to be the toughest decision I've had to make so far. I read that the stock could drop by as much as 30% if the tariffs go through. I've read mostly positive feedback from 5i on MG. Can you help quantify the risk over the next 2 months to a year?
Thanks

Q: I had just recently bought this company in my TFSA prior to the 2nd quarter earnings report, and the stock has dropped over 25% since my initial purchase. It would seem that 5i still likes the company do you consider the market reaction overblown, would you consider averaging down with this company or would you hold the position for the longer term.
Thanks Tom

Q: Why PHO share price keeps going down ? Thanks

Q: Is this continued drop in price still related to the last quarters results?

Q: Which companies do you like better than MG in the consumer cyclical sector for a growth-oriented investor focused on the long term?